Literature DB >> 7675765

Mutations of p53 in Wilms' tumors.

S Takeuchi1, C R Bartram, R Ludwig, B Royer-Pokora, S Schneider, J Imamura, H P Koeffler.   

Abstract

Mutations of p53 frequently occur in a wide variety of cancers including lung, breast, gastrointestinal, brain, and hematologic malignancies. These alterations apparently contributed to development of the malignant phenotype. Wilms' tumor is one of the most common solid tumors in childhood. The frequency of p53 alterations in this tumor is unknown. We analyzed 66 Wilms' tumor samples for p53 mutations by single-stand conformational polymorphism (SSCP) following polymerase chain reaction (PCR). Samples with an abnormal SSCP pattern were reamplified and analyzed by direct sequencing method. Mutations of p53 were found in three (5%) of 66 Wilms' tumors within the coding region (exons 2-11), showing that the frequency of p53 mutations was low. Two mutations substituted amino acids residues and one encoded a stop codon. Two of the mutations were located in the mutational hotspots (exons 5 and 6); the other was in exon 10. These data suggest that p53 mutations are infrequent in the development of Wilms' tumors.

Entities:  

Mesh:

Year:  1995        PMID: 7675765

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  6 in total

1.  Molecular and epidemiologic characterization of Wilms tumor from Baghdad, Iraq.

Authors:  Hannah M Phelps; Mazin F Al-Jadiry; Natasha M Corbitt; Janene M Pierce; Bingshan Li; Qiang Wei; Raina R Flores; Hernan Correa; Stefania Uccini; Haydar Frangoul; Adel R Alsaadawi; Safaa A F Al-Badri; Amir F Al-Darraji; Raghad M Al-Saeed; Salma A Al-Hadad; Harold N Lovvorn Iii
Journal:  World J Pediatr       Date:  2018-08-28       Impact factor: 2.764

2.  Anaplastic histology Wilms' tumors registered to the Japan Wilms' Tumor Study Group are less aggressive than that in the National Wilms' Tumor Study 5.

Authors:  Takaharu Oue; Tsugumichi Koshinaga; Tetsuya Takimoto; Hajime Okita; Yukichi Tanaka; Miwako Nozaki; Masayuki Haruta; Yasuhiko Kaneko; Masahiro Fukuzawa
Journal:  Pediatr Surg Int       Date:  2016-07-29       Impact factor: 1.827

3.  Immunohistochemical detection of p53 in Wilms' tumors correlates with unfavorable outcome.

Authors:  C Lahoti; P Thorner; D Malkin; H Yeger
Journal:  Am J Pathol       Date:  1996-05       Impact factor: 4.307

Review 4.  Malignant rhabdoid tumor of the colon: report of a case.

Authors:  I Nakamura; K Nakano; K Nakayama; Y Ishii; K Ohta; M Takahashi; T Yamada; K Yamaguchi; H Sakuma; A Tsuchiya; S Takenoshita
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

5.  Analyzing the gene expression profile of anaplastic histology Wilms' tumor with real-time polymerase chain reaction arrays.

Authors:  Jun Lu; Yan-Fang Tao; Zhi-Heng Li; Lan Cao; Shao-Yan Hu; Na-Na Wang; Xiao-Juan Du; Li-Chao Sun; Wen-Li Zhao; Pei-Fang Xiao; Fang Fang; Li-Xiao Xu; Yan-Hong Li; Gang Li; He Zhao; Jian Ni; Jian Wang; Xing Feng; Jian Pan
Journal:  Cancer Cell Int       Date:  2015-04-20       Impact factor: 5.722

6.  TP53 mutational status is a potential marker for risk stratification in Wilms tumour with diffuse anaplasia.

Authors:  Mariana Maschietto; Richard D Williams; Tasnim Chagtai; Sergey D Popov; Neil J Sebire; Gordan Vujanic; Elizabeth Perlman; James R Anderson; Paul Grundy; Jeffrey S Dome; Kathy Pritchard-Jones
Journal:  PLoS One       Date:  2014-10-14       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.